Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-10

Clinical Trial Update: Prevention of Severe Hypoglycaemia With Hypo-Safe Hypoglycaemia Alarm Device [NA]

View source ↗

Summary

A clinical trial evaluating a hypo-alert device to prevent severe hypoglycemia in Type 1 diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypo-Safe Hypoglycaemia Alarm Device

Snippet

Sponsor: UNEEG Medical A/S | Conditions: Type 1 Diabetes | NA | Status: WITHDRAWN